Research project
Myeloma UK Trials and Innovation At ÂÌñ»»ÆÞ
- Start date: 2026
- End date: 2029
- Funder: Myeloma UK
- Value: £494,999.98
- Partners and collaborators: Myeloma UK
- Primary investigator: Professor Sarah R Brown
- Co-investigators: Dr Chris Parrish
Description
The MyeTRIAL (Myeloma UK TRials and Innovation At ÂÌñ»»ÆÞ) Partnership puts patients in the driving seat of improving myeloma treatment and care. It is led by , consultant haemetologist at ÂÌñ»»ÆÞ Teaching Hospitals NHS Trust and Associate Professor at the ÂÌñ»»ÆÞ.
Myeloma UK are proud to work alongside the ÂÌñ»»ÆÞ Clinical Trials Research Unit (CTRU), bringing together our patient insight and expertise with the CTRU team’s incredible track record in myeloma trials. Together, we help to shape myeloma trials that create the change people living with myeloma need most.